Synthesis and characterization of insulin-transferrin conjugates

Bioconjugate Chemistry

Volumn 17, Issue 6, 2006, Pages 1376-1384

  Kavimandan, Nikhil J ^a   Losi, Elena ^a,c   Wilson, Jeffrey J ^b   Brodbelt, Jennifer S ^b   Peppas, Nicholas A ^a  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOSYNTHESIS; COVALENT BONDS; ELECTRODEPOSITION; ELECTROSPRAY IONIZATION; HYDROGELS; MASS SPECTROMETRY; MOLECULAR BIOLOGY; PROTEINS; SULFUR COMPOUNDS;

COMBINATION STRATEGIES; DIABETIC RATS; DISULPHIDE BONDS; ELECTROSPRAY IONIZATION MASS SPECTROMETRY; ENZYMATIC DEGRADATION; ORAL BIOAVAILABILITIES; ORAL DELIVERY; RECEPTOR-MEDIATED ENDOCYTOSIS; SYNTHESIS AND CHARACTERIZATIONS; THERAPEUTIC PROTEIN;

INSULIN;

INSULIN; PEPTIDE; PROTEIN; TRANSFERRIN;

ARTICLE; COMPLEX FORMATION; CONJUGATE; CONJUGATION; CONTROLLED STUDY; DIABETES MELLITUS; DISULFIDE BOND; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; ENDOCYTOSIS; ENZYMATIC DEGRADATION; HYDROGEL; INSULIN SYNTHESIS; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TRANSPORT; TRANSCYTOSIS;

EID: 33845220586     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc050344k     Document Type: Article

References (26)

1. Lowman, A. M., Morishita, M., Kajita, M., Nagai, T., and Peppas, N. A. (1999) Oral delivery of insulin using pH-responsive complexation gels. J. Pharm. Sci. 88, 933-937.
2. Morishita, M., Lowman, A. M., Takayama, K., Nagai, T., and Peppas, N. A. (2002) Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J. Controlled Release 81, 25-32.
3. Lowman, A. M., and Peppas, N. A. (1997) Analysis of the complexation/decomplexation phenomena in graft copolymer networks. Macromolecules 30, 4959-4965.
4. Lopez, J. E., and Peppas, N. A. (2004) Effect of poly(ethylene glycol) molecular weight and microparticle size on oral insulin delivery from P(MAA-g-EG) microparticles. Drug Dev. Ind. Pharm. 30, 497-504.
5. Lopez, J. E., and Peppas, N. A. (2004) Cellular evaluation of insulin transmucosal delivery. J. Biomater. Sci., Polym. Ed. 15, 385-396.
6. Gosk, S., Vermehren, C., Storm, G., and Moos, T. (2004) Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion. J. Cereb. Blood Flow Metab. 24, 1193-1204.
7. Vinogradov, S. V., Batrakova, E. V., and Kabanov, A. V. (2004) Nanogels for oligonucleotide delivery to the brain. Bioconjugate Chem. 15, 50-60.
8. Burdo, J. R., Antonetti, D. A., Wolpert, E. B., and Connor, J. R. (2003) Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system. Neuroscience 121, 883-890.
9. Bickel, U., Yoshikawa, T., and Pardridge, W. M. (2001) Delivery of peptides and proteins through the blood-brain barrier. Adv. Drug Delivery Rev. 46, 247-279.
10. Qian, Z. M., Li, H., Sun, H., and Ho, K. (2002) Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54, 561-587.
11. Li, H., and Qian, Z. M. (2002) Transferrin/transferrin receptor-mediated drug delivery. Med. Res. Rev. 22, 225-250.
12. Xia, C. Q., Wang, J., and Shen, W. C. (2000) Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats. J. Pharmacol. Exp. Ther. 295, 594-600.
13. Shah, D., and Shen, W. C. (1996) Transcellular delivery of an insulin-transferrin conjugate in enterocyte-like Caco-2 cells. J. Pharm. Sci. 85, 1306-1311.
14. Lim, C. J., and Shen, W. C. (2005) Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs. J. Controlled Release 106, 273-286.
15. Widera, A., Bai, Y., and Shen, W. C. (2004) The transepithelial transport of a G-CSF - transferrin conjugate in Caco-2 cells and its myelopoietic effect in BDF1 mice. Pharm. Res. 21, 278-284.
16. Carlsson, J., Drevin, H., and Axen, R. (1978) Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio) propionate, a new heterobifunctional reagent. Biochem. J. 173, 723-737.
17. Stuchbury, T., Shipton, M., Morris, R., Malthouse, J. P., Brocklehurst, K., Herbert, J. A., and Suschitzky, H. (1975) A reporter group delivery system with both absolute and selective specificity for thiol groups and an improved fluorescent probe containing the 7-nitrobenzo-2-oxa-1, 3-diazole moiety. Biochem. J. 151, 417-432.
18. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
19. Mei, H., Yu, C., and Chan, K. K. (1999) NB1-C16-insulin: site-specific synthesis, purification, and biological activity. Pharm. Res. 16, 1680-1686.
20. Lorenzen, A., and Kennedy, S. W. (1993) A fluorescence-based protein assay for use with a microplate reader. Anal. Biochem. 214, 346-348.
21. Garnett, M. C. (2001) Targeted drug conjugates: principles and progress. Adv. Drug Delivery Rev. 53, 171-216.
22. Melton, R. G., and Sherwood, R. F. (1996) Antibody-enzyme conjugates for cancer therapy. J. Natl. Cancer Inst. 88, 153-165.
23. Saito, G., Swanson, J. A., and Lee, K. D. (2003) Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Delivery Rev. 55, 199-215.
24. Thorpe, P. E., Wallace, P. M., Knowles, P. P., Relf, M. G., Brown, A. N., Watson, G. J., Knyba, R. E., Wawrzynczak, E. J., and Blakey, D. C. (1987) New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Cancer Res. 47, 5924-5931.
25. Lindsay, D. G., and Shall, S. (1971) The acetylation of insulin. Biochem. J. 121, 737-745.
26. Udenfriend, S., Stein, S., Bohlen, P., Dairman, W., Leimgruber, W., and Weigele, M. (1972) Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178, 871-87.